Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
Clinical trial NCT04471428 · COMPLETED
Trial details
- NCT number
- NCT04471428
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-09-28
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.